BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20637013)

  • 1. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
    Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.
    Audard V; Kamar N; Sahali D; Cardeau-Desangles I; Homs S; Remy P; Aouizerate J; Matignon M; Rostaing L; Lang P; Grimbert P
    Transpl Int; 2012 May; 25(5):e62-6. PubMed ID: 22409658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
    Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY
    Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
    Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of recurrent focal segmental glomerulosclerosis after renal transplantation by lymphocytapheresis and rituximab.
    Shimizu M; Kitagawa K; Nishio S; Yokoyama T; Furuichi K; Ohta K; Wada T; Yachie A
    Transpl Int; 2010 Sep; 23(9):e53-5. PubMed ID: 20536913
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of recurrent focal segmental glomerulosclerosis (FSGS) involving massive proteinuria (>50 g/day) immediately after renal transplantation.
    Okamoto M; Koshino K; Sakai K; Nobori S; Matsuyama M; Ushigome H; Okajima H; Masuzawa N; Yoshimura N
    Clin Transplant; 2011 Jul; 25 Suppl 23():53-8. PubMed ID: 21623916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.
    Matalon A; Markowitz GS; Joseph RE; Cohen DJ; Saal SD; Kaplan B; D'Agati VD; Appel GB
    Clin Nephrol; 2001 Oct; 56(4):271-8. PubMed ID: 11680656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.
    Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F
    Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis.
    Garcia CD; Bittencourt VB; Tumelero A; Antonello JS; Malheiros D; Garcia VD
    Transplant Proc; 2006; 38(6):1904-5. PubMed ID: 16908318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
    Cho JH; Lee JH; Park GY; Lim JH; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
    Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence.
    Chikamoto H; Hattori M; Kuroda N; Kajiho Y; Matsumura H; Fujii H; Ishizuka K; Hisano M; Akioka Y; Nozu K; Kaito H; Shimizu M
    Pediatr Transplant; 2012 Nov; 16(7):E286-90. PubMed ID: 22129369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.
    Hickson LJ; Gera M; Amer H; Iqbal CW; Moore TB; Milliner DS; Cosio FG; Larson TS; Stegall MD; Ishitani MB; Gloor JM; Griffin MD
    Transplantation; 2009 Apr; 87(8):1232-9. PubMed ID: 19384172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient.
    Sakai K; Takasu J; Nihei H; Yonekura T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A
    Clin Transplant; 2010 Jul; 24 Suppl 22():60-5. PubMed ID: 20590697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
    Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic apheresis rescue mission: recurrent focal segmental glomerulosclerosis in renal allografts.
    Keith DS
    Semin Dial; 2012; 25(2):190-2. PubMed ID: 22175233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report.
    Dęborska-Materkowska D; Kozińska-Przybył O; Mikaszewska-Sokolewicz M; Durlik M
    Transplant Proc; 2014 Oct; 46(8):2908-11. PubMed ID: 25380948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis for the prophylaxis and treatment of recurrent focal segmental glomerulosclerosis following renal transplant.
    Valdivia P; Gonzalez Roncero F; Gentil MA; Jiménez F; Algarra G; Pereira P; Rivera M; Suñer M; Cabello V; Toro J; Mateos J
    Transplant Proc; 2005 Apr; 37(3):1473-4. PubMed ID: 15866644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.